Monday, October 10, 2016

Beechams Veno’s Cough Mixture





1. Name Of The Medicinal Product



Beechams Veno's Cough Mixture



Veno's Cough Syrup


2. Qualitative And Quantitative Composition



Glucose liquid 3.18 g, Treacle 1.35 g



For excipients, see 6.1.



3. Pharmaceutical Form



Syrup



4. Clinical Particulars



4.1 Therapeutic Indications



Recommended for the symptomatic relief of sore throat and unproductive cough in minor respiratory tract infections.



4.2 Posology And Method Of Administration



Adults and children over the age of 12: Take one 5 ml or 10 ml dose (one or two 5 ml spoonfuls). Repeat the dose every 2 or 3 hours.



Children aged 3 to under 12 years: Take one 5 ml dose (one 5 ml spoonful) and give every 2 to 3 hours. Do not give to children under 3 years except on medical advice.



Route of Administration



Oral



4.3 Contraindications



Hypersensitivity to glucose, treacle or any other of the ingredients.



4.4 Special Warnings And Precautions For Use



Special Label Warnings



Keep all medicines out of the sight and reach of children.



If symptoms persist consult your doctor.



Total sugars content 3.6 g per 5 ml.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



None



4.6 Pregnancy And Lactation



Use in pregnancy and lactation is not contraindicated. However, as with all medicines, caution should be exercised during pregnancy and lactation.



4.7 Effects On Ability To Drive And Use Machines



None



4.8 Undesirable Effects



Immune system disorders



Hypersensitivity reactions e.g. skin rash



4.9 Overdose



The product does not contain any ingredient in a high enough concentration to cause toxic effects; therefore no specific symptoms of overdosage would be anticipated and no antidotes would be required.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Treacle and glucose liquid are demulcents, which will help relieve an unproductive cough and will soothe a sore throat.



5.2 Pharmacokinetic Properties



None Stated.



5.3 Preclinical Safety Data



There are no preclinical data of any relevance additional to that already included in other sections of the SmPC.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Capsicum tincture, aniseed oil, xanthan gum, camphor racemic, glacial acetic acid, sodium benzoate, sodium metabisulphite (E223), levomenthol, water and colour caramel (E150).



6.2 Incompatibilities



None



6.3 Shelf Life



Unopened: Three years



Opened: Six months



6.4 Special Precautions For Storage



None



6.5 Nature And Contents Of Container



Clear glass bottle with a roll-on, pilfer proof, aluminium cap containing a melinex-coated aluminium-faced pulp-board wad. The bottle is contained in a boxboard carton.



Pack sizes: 100 ml, 160 ml.



Not all pack sizes may be marketed.



6.6 Special Precautions For Disposal And Other Handling



None



Administrative Data


7. Marketing Authorisation Holder



Beecham Group plc



980 Great West Road



Brentford



Middlesex



TW8 9GS



United Kingdom



Trading as:



GlaxoSmithKline Consumer Healthcare, Brentford, TW8 9GS, U.K.



8. Marketing Authorisation Number(S)



PL 00079/0157R



9. Date Of First Authorisation/Renewal Of The Authorisation



28 September 1988 / 9 November 1993



10. Date Of Revision Of The Text



01/12/2010





No comments:

Post a Comment